PATOLOJİ UZMANI

Prof. Dr. Ömer Yerci

 Öğrenim Durumu:
  •   1988 Uludağ Üniversitesi Tıbbi Patoloji Uzmanlık Eğitimi
  •   1979 Çukurova Üniversitesi, Tıp Fakültesi Tıp Doktoru

 Profesyonel Deneyim:

  • 01.01.2024 Biyotıp Patoloji
  • 2001 2023 Uludağ Üniversitesi, Tıp Fakültesi Tıbbi Patoloji Profesör Dr.
  • 1995 2001 Uludağ Üniversitesi, Tıp Fakültesi Tıbbi Patoloji Doçent Dr.
  • 1992 – 1993 Hannover (ALMANYA)-Sitopatoloji
  • 1991 1995 Uludağ Üniversitesi, Tıp Fakültesi Tıbbi Patoloji Yardmcı Doçent Dr.
  • 1988 1991 Uludağ Üniversitesi, Tıp Fakültesi Tıbbi Patoloji Uzman Dr.
  • 1985 1988 Uludağ Üniversitesi, Tıp Fakültesi Tıbbi Patoloji Araştırma görevlisi

 İdari Görevler

  • 2006 -2009 Tıbbi Patoloji AD.Başkanlığı
  • 2009 -2011 Uludağ Üniversitesi, Tıp Fakültesi Dekan Yardımcılığı
  • 2015-2015 Uludağ Üniversitesi, Tıp Fakültesi Dekan Yardımcılığı
  • 2014 - 2017 Tıbbi Patoloji AD.Başkanlığı

 
 
 YAYINLAR

1- Kolon ve rektum karsinomlarında müsinöz komponent

Ö Yerci, G FİLİZ, A ZORLUOĞLU, S ÖZUYSAL… - Patoloji Bülteni, 1998

 

2- Stromal Tumors

MD Ulviye Yalcinkaya, MD Omer Yerci… - Hepato …, 2007 - G. Thieme.

 

3- Kolorektal karsinomalarda immünohistokimyasal c-erbB-2, p53, bcl-2 ekspresyonu ile apoptotik, proliferatif indeks ve diğer prognostik faktörler arasındaki

Ö Yerci, G FİLİZ, S ÖZUYSAL, S GÜREL - Patoloji Bülteni, 1999

 

4- Renal cell karsinoma larda P-Glikoprotein salınımı ve Ki-67 proliferatif aktivitesinin multipl prognostik faktörlerle ilişkisi

Ö Yerci, G FİLİZ, S ÖZUYSAL, İ YAVAŞÇAOĞLU… - Patoloji Bülteni, 1998

 

5- Pankreas lezyonlarının tanısında ince iğne aspirasyon biyopsisinin           yeri

Ö Yerci, S GÜREL, H ÖZTÜRK, E DOLAR, ADIM… - Turkish Journal of …, 1999

 

6- General characteristics of the perinatal autopsies performed in our clinic in 2006

U Yalcinkaya, O Yerci - VIRCHOWS ARCHIV, 2007 - SPRINGER 233 SPRING           STREET

 

7- Gastrointestinal sistem lezyonlarının tanısında sitolojinin yeri

Ö Yerci, S GÜREL, G FİLİZ, ADIM, Y KARAASLAN… - Patoloji Bülteni, 1999

 

8- Mesenchymal tumors of the gastrointestinal tract Gastrointestinal sistemin mezensimal tumorleri

Ö Yerci İ, S GÜREL, Ş BALABAN ADIM… - Turkish Journal of …, 1999

 

9- Meme lezyonlarının retrospektif incelenmesi (724 olgu) Ö Yerci, Z Gücin, O Erol, Ş Tolunay, S Özuysal 1990

 

10- Tiroid İnce İğne Aspirasyon Biyopsilerinin Değerlendirilmesi

Ö Yerci , G FİLİZ, S ÖZUYSAL… - Türkiye Ekopatoloji …, 1997


 

 

 

11- Somatostatin receptor 2 and 5 expressions in gastroenteropancreatic neuroendocrine tumors in Turkey

O Yerci, I Sehitoglu, N Ugras, E Cubukcu - Asian Pacific Journal …, 2015

 

12.   Periampullary carcinomas.

Filiz G, Yerci O, Adim SB, Gurel S, Dolar E, Memik F. Hepatogastroenterology. 2007 Jun;54(76):1247-9.

PMID: 17629080

13.   IgG4-Related Disease of the Ovary. Akyol S, Atalay FÖ, Hasdemir S, Yerci Ö.

Turk Patoloji Derg. 2021;37(1):63-66. doi: 10.5146/tjpath.2020.01500. PMID: 32779156 Free PMC article.

14.   Thymic tumors and results of radiotherapy.

Sarıhan S, Bayram AS, Gebitekin C, Yerci O, Sıgırlı D.

Rep Pract Oncol Radiother. 2018 Mar-Apr;23(2):97-104. doi: 10.1016/j.rpor.2017.12.002. Epub 2018 Feb 12.

PMID: 29681772 Free PMC article.

15.   SOCS-1 1478 CA/del gene polymorphism affects survival in colorectal carcinoma.

Ayyildiz T, Dolar E, Oral B, Erturk B, Haktanir AE, Adim SB, Yerci O.

Niger J Clin Pract. 2022 Mar;25(3):239-247. doi: 10.4103/njcp.njcp_1309_21. PMID: 35295043

16.   The expression and relationship of AdipoR1/R2 in gastric intestinal metaplasia.

Ayyildiz T, Dolar E, Ugras N, Dizdar OS, Erturk B, Adim SB, Yercı O.

Niger J Clin Pract. 2021 Apr;24(4):608-613. doi: 10.4103/njcp.njcp_302_20. PMID: 33851685

17.   Acquired lymphangiectasis after breast conservation treatment for breast cancer: report of a case.

Tasdelen I, Gokgoz S, Paksoy E, Yerci O, Cetintas SK, Demiray M, Samsa V.

Dermatol Online J. 2004 Jul 15;10(1):9.

PMID: 15347491 Review.

18.   Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis.

Ak Aksoy S, Tunca B, Erçelik M, Tezcan G, Ozturk E, Cecener G, Ugras N, Yilmazlar T, Yerci O.

Mol Biol Rep. 2022 Dec;49(12):11243-11253. doi: 10.1007/s11033-022- 07680-y. Epub 2022 Jul 6.

PMID: 35794508

19.   Liver metastasis of breast carcinoma: An unusual presentation and growth pattern.

Özşen M, Uğraş N, Yerci Ö, Deligönül A.


 

Indian J Pathol Microbiol. 2023 Oct-Dec;66(4):877-879. doi: 10.4103/ijpm.ijpm_1235_21.

PMID: 38084555

20.   Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors?

Ugras N, Hasdemir S, Yerci Ö, Taşar P, Dündar HZ, Macunluoğlu AC. Tumori. 2021 Feb;107(1):80-85. doi: 10.1177/0300891620941921. Epub 2020 Jul 24.

PMID: 32705937

21.   Anorectal malignant melanomas: experience of Uludag University. Aytac B, Adim SB, Yerci O, Yilmazlar T.

Kaohsiung J Med Sci. 2010 Dec;26(12):658-62. doi: 10.1016/S1607- 551X(10)70100-5.

PMID: 21186014

22.   Helicobacter pylori and intestinal metaplasia.

Evrensel T, Manavoğlu O, Ozyardimci C, Gülten M, Nak SG, Yerci O. J Environ Pathol Toxicol Oncol. 1996;15(2-4):215-9.PMID: 9216809

23.   TWO OPPOSITE PHENOTYPES OF GLUCOSE DISORDERS IN A FAMILY WITH HETEROZYGOUS P.SER453LEU (C.1358C> T) MUTATION IN THE GLUCOKINASE (GCK) GENE: MATURITY ONSET DIABETES IN YOUNG AND INSULINOMA.

Demiral M, Çelebi HBG, Cander S, Yerci O, Eren E, Demirbilek H. Acta Endocrinol (Buchar). 2022 Oct-Dec;18(4):458-465. doi: 10.4183/aeb.2022.458.

PMID: 37152879 Free PMC article.

24.   Adipo-R1 and adipo-R2 expression in colorectal adenomas and carcinomas. Ayyildiz T, Dolar E, Ugras N, Eminler AT, Erturk B, Adim SB, Yerci O.

Asian Pac J Cancer Prev. 2015;16(1):367-72. doi: 10.7314/apjcp.2015.16.1.367.

PMID: 25640382

25.   Lack of prognostic significance of SOCS-1 expression in colorectal adenocarcinomas.

Ayyildiz T, Dolar E, Adim SB, Eminler AT, Yerci O. Asian Pac J Cancer Prev. 2014;15(19):8469-74. doi: 10.7314/apjcp.2014.15.19.8469.

PMID: 25339048

26.   MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.

Ak S, Tunca B, Tezcan G, Cecener G, Egeli U, Yilmazlar T, Ozturk E, Yerci O.

J Surg Res. 2014 Sep;191(1):113-22. doi: 10.1016/j.jss.2014.03.057. Epub 2014 Mar 24.

PMID: 24746948

27.   Maspin expression in gastrointestinal stromal tumors. Adim SB, Filiz G, Kanat O, Yerci O, Ozguc H, Aytac B.


 

World J Surg Oncol. 2010 Mar 26;8:22. doi: 10.1186/1477-7819-8-22.

PMID: 20346150 Free PMC article.

28.   Association of adiponectin receptor (Adipo-R1/-R2) expression and colorectal cancer.

Ayyildiz T, Dolar E, Ugras N, Adim SB, Yerci O. Asian Pac J Cancer Prev. 2014;15(21):9385-90. doi: 10.7314/apjcp.2014.15.21.9385.

PMID: 25422229

29.   Perforation of the small intestine caused by enteropathy-associated T cell lymphoma.

Kabul S, Uğraş N, Yerci Ö, Öztürk E.

Turk J Surg. 2018 Jan 3;34(3):253-255. doi: 10.5152/turkjsurg.2017.3278. eCollection 2018.

PMID: 30302434 Free PMC article.

30.   Retrospective analysis of clinicopathological features of solid pseudopapillary neoplasm of the pancreas.

Ugras N, Yerci Ö, Coşkun SK, Ocakoğlu G, Sarkut P, Dündar HZ. Kaohsiung J Med Sci. 2016 Jul;32(7):356-61. doi: 10.1016/j.kjms.2016.05.009. Epub 2016 Jun 11.

PMID: 27450024

31.   Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation.

Dundar HZ, Aksoy F, Aksoy SA, Tasar P, Ugras N, Tunca B, Egeli U, Cecener G, Yerci O, Kaya E.

Transplant Proc. 2019 May;51(4):1157-1161. doi: 10.1016/j.transproceed.2019.01.089. Epub 2019 Feb 8.

PMID: 31101191

32.   Primary leptomeningeal lymphoma simulating chronic meningitis. Heper Y, Mistik R, Yerci O, Altintas F, Akalin H.

Clin Microbiol Infect. 1997 Feb;3(6):695-696. doi: 10.1111/j.1469- 0691.1997.tb00481.x.

PMID: 11864216 No abstract available.

33.   Analysis of mismatch repair gene mutations in Turkish HNPCC patients. Tunca B, Pedroni M, Cecener G, Egeli U, Borsi E, Zorluoglu A, Di Gregorio C, Yilmazlar T, Yerci O, de Leon MP.

Fam Cancer. 2010 Sep;9(3):365-76. doi: 10.1007/s10689-010-9336-7. PMID: 20373145

34.   Somatostatin receptor 2 and 5 expressions in gastroenteropancreatic neuroendocrine tumors in Turkey.

Yerci O, Sehitoglu I, Ugras N, Cubukcu E, Yuce S, Bedir R, Cure E. Asian Pac J Cancer Prev. 2015;16(10):4377-81. doi: 10.7314/apjcp.2015.16.10.4377.

PMID: 26028102

35.   The diagnostic value of endoscopic narrow band imaging in helicobacter


 

pylori gastritis in children.

Özgür T, Özkan TB, Erdemir G, Özakın C, Yerci Ö.

Turk J Gastroenterol. 2015 Mar;26(2):112-6. doi: 10.5152/tjg.2015.6717. PMID: 25835107

36.   Overexpression of the Long Noncoding RNA HomeoboxA Transcript at the Distal Tip Predicts Poor Prognosis in a KRAS-Independent Manner in Periampullary Region Tumors.

Balcin O, Ak Aksoy S, Tunca B, Kaya E, Egeli U, Tezcan G, Ugras N, Cecener G, Isik O, Dundar HZ, Yerci O.

Pancreas. 2018 Feb;47(2):213-220. doi: 10.1097/MPA.0000000000000984. PMID: 29329159

37.   Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients.

Ak S, Tunca B, Yilmazlar T, Tezcan G, Cecener G, Egeli U, Ozturk E, Yerci O, Ertürk E, Zorluoglu A.

J Surg Res. 2013 Dec;185(2):626-37. doi: 10.1016/j.jss.2013.07.014. Epub 2013 Jul 31.

PMID: 23992855

38.   Metastatic/resected lymph nodes ratio-based classification in gastric cancer. Ozgüç H, Sönmez Y, Yerci O.

Turk J Gastroenterol. 2008 Mar;19(1):2-7. PMID: 18386233

39.   Expression of p53 protein and prognosis in gastric carcinoma.

Gürel S, Dolar E, Yerci O, Samli B, Oztürk H, Nak SG, Gülten M, Memik F. J Int Med Res. 1999 Mar-Apr;27(2):85-9. doi: 10.1177/030006059902700205.

PMID: 10446695

40.   Coexistence of gastric multiple neuroendocrine tumors with unusual morphological features and gastric signet-ring cell carcinoma. Uğraş N, Sarkut P, Yerci Ö, Öztürk E.

Turk J Surg. 2018 Jan 3;34(2):152-154. doi: 10.5152/turkjsurg.2017.3279. eCollection 2018.

PMID: 30023984 Free PMC article.

41.   Gastrointestinal stromal tumors: A multicenter study of 1160 Turkish cases. Bülbül Doğusoy G; Turkish GIST Working Group.

Turk J Gastroenterol. 2012 Jun;23(3):203-11. PMID: 22798108

42.   Malignant glomus tumor with oncocytic features: an unusual presentation of dysphagia.

Ugras N, Yercİ Ö, Yalçınkaya U, Gülcü B, Öztürk E, Yıldırım Ç, Çavuşoğlu İ. APMIS. 2015 Jul;123(7):613-7. doi: 10.1111/apm.12394. Epub 2015 Apr 23.

PMID: 25908295

43.   Microscopic Growth Pattern of Metastatic Colorectal Carcinomas, Morphological Findings of the Non-Neoplastic Liver, and Their Relationship With Prognosis and Survival.


 

Özşen M, Uğraş N, Yerci Ö, Deligonul A, Taşar P, Işık Ö, Yılmazlar T. Int J Surg Pathol. 2024 Feb 8:10668969241226702. doi: 10.1177/10668969241226702. Online ahead of print.PMID: 38332662

44.   Subtypes of intestinal metaplasia and their relationship to Helicobacter pylori. Evrensel T, Manavoğlu O, Ozyardimci C, Orhan B, Gülten M, Nak SG, Yerci O.

J Environ Pathol Toxicol Oncol. 1996;15(2-4):221-4. PMID: 9216810

45.   Can heat shock protein 32 be used for the early diagnosis of acute mesenteric ischemia?

Berhuni S, Öztürk E, Oral AY, Sarkut P, Kahveci N, Yılmazlar T, Özlük K, Yerci Ö.

Ulus Cerrahi Derg. 2016 Mar 1;32(1):1-5. doi: 10.5152/UCD.2015.3096.

eCollection 2016.

PMID: 26985164 Free PMC article.

46.   Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.

Ozturk E, Aksoy SA, Ugras N, Tunca B, Ceylan S, Tezcan G, Yilmazlar T, Yerci O, Egeli U, Cecener G.

APMIS. 2018 Feb;126(2):99-108. doi: 10.1111/apm.12801. PMID: 29700912

47.   Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients.

Tunca B, Tezcan G, Cecener G, Egeli U, Zorluoglu A, Yilmazlar T, Ak S, Yerci O, Ozturk E, Umut G, Evrensel T.

J Cancer Res Clin Oncol. 2013 Apr;139(4):691-702. doi: 10.1007/s00432- 013-1372-x. Epub 2013 Jan 16.

PMID: 23322277

48.   Immunohistochemical expression of CDX2, CK7, HER2 and HER4 in periampullary adenocarcinoma : implications for clinicopathology and patient outcomes.

Uğraş N, Yerci Ö, Özgün G, Deligönül A, Dündar HZ, Sarkut P, Kanat Ö. Acta Gastroenterol Belg. 2017 Jan-Mar;80(1):31-37.

PMID: 29364095

49.   Does fibrin glue cause foreign body reactions? Sanal M, Doğruyol H, Gürpinar A, Yerci O.

Eur J Pediatr Surg. 1992 Oct;2(5):285-6. doi: 10.1055/s-2008-1063460. PMID: 1420074

50.   Lack of any prognostic relationship between adiponectin receptor (Adipo R1/R2) expression for early/advanced stage gastric cancer.

Ayyildiz T, Dolar E, Ugras N, Dizdar OS, Adim SB, Yerci O. Asian Pac J Cancer Prev. 2014;15(11):4711-6. doi: 10.7314/apjcp.2014.15.11.4711.

PMID: 24969908


 

51.   Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

Kiyici M, Gulten M, Gurel S, Nak SG, Dolar E, Savci G, Adim SB, Yerci O, Memik F.

Can J Gastroenterol. 2003 Dec;17(12):713-8. doi: 10.1155/2003/857869. PMID: 14679419 Clinical Trial.

52.   miR-216b Targets FGFR1 and Confers Sensitivity to Radiotherapy in Pancreatic Ductal Adenocarcinoma Patients Without EGFR or KRAS Mutation.

Egeli U, Tezcan G, Cecener G, Tunca B, Demirdogen Sevinc E, Kaya E, Ak S, Dundar HZ, Sarkut P, Ugras N, Yerci O, Ozen Y, Evrensel T.

Pancreas. 2016 Oct;45(9):1294-302. doi: 10.1097/MPA.0000000000000640. PMID: 27101576

53.   P53 expression in synchronous colorectal cancer. Yalcinkaya U, Ozturk E, Ozgur T, Yerci O, Yilmazlar T. Saudi Med J. 2008 Jun;29(6):826-31.

PMID: 18521459

54.   Impact of 3 UTR variation patterns of the KRAS gene on the aggressiveness of pancreatobiliary tumors with the KRAS G13D mutation in a Turkish population.

Egeli U, Ak S, Cecener G, Tunca B, Tezcan G, Sevinc ED, Kaya E, Dundar HZ, Sarkut P, Ozen Y, Balcin O, Evrensel T, Yerci O, Ugras N. Pancreatology. 2016 Jul-Aug;16(4):677-86. doi: 10.1016/j.pan.2016.05.004. Epub 2016 May 24.

PMID: 27256640

55.   A rare tumor located in the anorectal junction: sarcomatoid carcinoma. Oztürk E, Yilmazlar T, Yerci O.

Turk J Gastroenterol. 2006 Sep;17(3):236-9. PMID: 16941264

56.   Small cell carcinoma of the rectum metastasizing to axillary lymph nodes: a case report.

Işik Ö, Öztürk E, Akar E, Yercı Ö, Yilmazlar T.

Turk J Gastroenterol. 2010 Dec;21(4):476-7. doi: 10.4318/tjg.2010.0146. PMID: 21332013 No abstract available.

57.   A comparison of three fibrinolytic agents in prevention of intra-abdominal adhesions.

Topal E, Ozturk E, Sen G, Yerci O, Yilmazlar T. Acta Chir Belg. 2010 Jan-Feb;110(1):71-5. doi: 10.1080/00015458.2010.11680569.

PMID: 20306914

58.   Splenic hemangiopericytoma and serosal cavernous hemangiomatosis of the adjacent colon.

Yilmazlar T, Kirdak T, Yerci O, Adim SB, Kanat O, Manavoglu O. World J Gastroenterol. 2005 Jul 14;11(26):4111-3. doi: 10.3748/wjg.v11.i26.4111.


 

PMID: 15996041 Free PMC article.

59.   Vena cava resection with venous-venous shunt for hemangioma. Bayram AS, Bicer M, Yerci O, Senkaya I, Gebitekin C.

Thorac Cardiovasc Surg. 2009 Dec;57(8):489-91. doi: 10.1055/s-0029- 1185337.

PMID: 20013625

60.   Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.

Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Yerci O, Oral AY, Gul CB, Gurel S, Nak SG, Gulten M.

Med Sci Monit. 2009 Apr;15(4):CR189-93. PMID: 19333204

61.   Superior vena cava syndrome: Initial presentation of acute myeloid leukemia (AML-M0) with near-tetraploidy+/TdT+/CD7+/CD34+/HLA-DR+.

Ali R, Ozkalemkas F, Yerci O, Ozcelik T, Gebitekin C, Ozkocaman V, Ozkan A, Budak F, Gulten T, Cetintas S, Tunali A.

Leuk Lymphoma. 2006 May;47(5):937-40. doi: 10.1080/10428190500398963.

PMID: 16753886 No abstract available.

62.   A retrospective analysis of thyroid cancer.

Ertürk E, Tuncel E, Yerci O, Gürsoy N, Imamoğlu S, Koran N, Arinik A. J Environ Pathol Toxicol Oncol. 1996;15(2-4):245-9.

PMID: 9216815

63.   Somatostatin receptor 1 (SSTR1) and somatostatin receptor 5 (SSTR5)expression in hepatocellular carcinoma.

Koc EU, Ozgur T, Yerci O, Gurel S. Hepatogastroenterology. 2013 Oct;60(127):1693-7.

PMID: 24634938

64.   A case of hemangiosarcoma in thyroid with severe anemia due to bone marrow metastasis.

Yilmazlar T, Kirdak T, Adim S, Ozturk E, Yerci O.

Endocr J. 2005 Feb;52(1):57-9. doi: 10.1507/endocrj.52.57. PMID: 15758558

65.   The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer.

Gürel S, Dolar E, Yerci O, Samli B, Oztürk H, Nak SG, Gülten M, Memik F. J Int Med Res. 1999 Mar-Apr;27(2):74-8. doi: 10.1177/030006059902700203.

PMID: 10446693

66.   The expression frequency of common fragile sites and genetic predisposition to colon cancer.

Tunca B, Egeli U, Zorluoglu A, Yilmazlar T, Yerci O, Kizil A.

Cancer Genet Cytogenet. 2000 Jun;119(2):139-45. doi: 10.1016/s0165- 4608(99)00228-9.

PMID: 10867150


 

67.   Relationship between HER-2, COX-2, p53 and clinicopathologic features in gastric adenocarcinoma. Do these biomarkers have any prognostic significance?

Ugraş N, Özgün G, Ocakoğlu G, Yerci Ö, Öztürk E. Turk J Gastroenterol. 2014 Dec;25 Suppl 1:176-81. doi: 10.5152/tjg.2014.5280.

PMID: 25910300

68.   Clinical significance of activity of ALT enzyme in patients with hepatitis C virus.

Akkaya O, Kiyici M, Yilmaz Y, Ulukaya E, Yerci O. World J Gastroenterol. 2007 Nov 7;13(41):5481-5. doi: 10.3748/wjg.v13.i41.5481.

PMID: 17907292 Free PMC article.

69.   Assessment of the efficacy of bio-absorbable oxidized regenerated cellulose for prevention of post-operative pericardial adhesion in the rabbit model. Biçer M, Bayram AS, Gürbüz O, Senkaya I, Yerci O, Tok M, Anğ E, Moğol EB, Saba D.

J Int Med Res. 2008 Nov-Dec;36(6):1311-8. doi: 10.1177/147323000803600619.

PMID: 19094441

70.   Total thyroidectomy or lobectomy in benign nodular disease of the thyroid: changing trends in surgery.

Korun N, Aşci C, Yilmazlar T, Duman H, Zorluoglu A, Tuncel E, Ertürk E, Yerci O.

Int Surg. 1997 Oct-Dec;82(4):417-9. PMID: 9412844

71.   The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases.

Ozkalemkas F, Ali R, Ozkocaman V, Ozcelik T, Ozan U, Ozturk H, Kurt E, Evrensel T, Yerci O, Tunali A.

BMC Cancer. 2005 Nov 1;5:144. doi: 10.1186/1471-2407-5-144.

PMID: 16262899 Free PMC article.

72.   Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study. Demiray M, Gulten M, Manavoglu O, Evrensel T, Ulukaya E, Yerci O, Kanat O, Kurt E, Arslan M, Gonullu G, Demiray H, Gulten T, Memik F. Hepatogastroenterology. 2004 Sep-Oct;51(59):1531-5.

PMID: 15362794

73.   High expression of multidrug resistance-1 (MDR-1) and its relationship with multiple prognostic factors in gastric carcinomas in patients in Turkey.

Gürel S, Yerci O, Filiz G, Dolar E, Yilmazlar T, Nak SG, Gülten M, Zorluoğlu A, Memik F.

J Int Med Res. 1999 Mar-Apr;27(2):79-84. doi: 10.1177/030006059902700204.

PMID: 10446694


 

74.   Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis.

Tunca B, Menigatti M, Benatti P, Egeli U, Cecener G, Pedroni M, Scarselli A, Borghi F, Sala E, Yilmazlar T, Zorluoglu A, Yerci O, de Leon MP.

Dis Colon Rectum. 2005 Mar;48(3):567-71. doi: 10.1007/s10350-004-0799- 1.

PMID: 15719192

75.   Simultaneous occurrence of synchronous and metachronous tumors with gastrointestinal stromal tumors.

Adim SB, Filiz G, Kanat O, Yerci O. Bratisl Lek Listy. 2011;112(11):623-5. PMID: 22180988

76.   Thyroid carcinoma with insular component: report of three cases with different clinical pictures.

Kirdak T, Saraydaroglu O, Duran C, Yerci O, Korun N.

Tumori. 2006 Sep-Oct;92(5):444-8. doi: 10.1177/030089160609200515. PMID: 17168441

77.   Multifocal early gastric adenocarcinomas with gastric lipomatosis: an unusual coexistence.

Ugras N, Kabul S, Yerci Ö, Oztürk E.

Indian J Pathol Microbiol. 2014 Oct-Dec;57(4):653-4. doi: 10.4103/0377- 4929.142721.

PMID: 25308037 No abstract available.

78.   Acardiac fetus: a case report. Ozuysal S, Yerci O, Uncu G, Filiz G.

Clin Exp Obstet Gynecol. 1997;24(3):169-70. PMID: 9478310 No abstract available.

79.   Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential.

Ozgüç H, Yilmazlar T, Yerci O, Soylu R, Tümay V, Filiz G, Zorluoglu A. J Gastrointest Surg. 2005 Mar;9(3):418-29. doi: 10.1016/j.gassur.2004.07.003.

PMID: 15749606

80.   A tumoral lesion that includes four distinct components: a gastric composite tumor with liver metastasis.

Uğraş N, Oz Atalay F, Yerci O, Kaya E.

Turk J Gastroenterol. 2014 Oct;25(5):590-1. doi: 10.5152/tjg.2014.4146.PMID: 25417630 No abstract available.

81.   The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives.

Tunca B, Egeli U, Zorluoğlu A, Yilmazlar T, Yerci O, Kizil A.

Cancer Lett. 2000 May 1;152(2):201-9. doi: 10.1016/s0304-3835(00)00334- 7.

PMID: 10773413

82.   The relationship between MIB-1 proliferative activity and mitotic index in


 

gastrointestinal stromal tumors.

Filiz G, Yalçinkaya O, Gürel S, Yerci O, Memik F. Hepatogastroenterology. 2007 Mar;54(74):438-41.

PMID: 17523292

83.   Significance of p53 expression in gastrointestinal stromal tumors. Yalcinkaya U, Yerci O, Koc EU.

Hepatogastroenterology. 2007 Jan-Feb;54(73):140-3.

PMID: 17419248

84.   Successful treatment of cranial metastases of extrapulmonary small cell carcinoma with chemotherapy alone.

Orhan B, Yalçin S, Evrensel T, Yerci O, Manavoğlu O.

Med Oncol. 1998 Apr;15(1):66-9. doi: 10.1007/BF02787348. PMID: 9643534

85.   Prognostic value of nm23 in gastrointestinal stromal tumors.

Kanat O, Adim S, Evrensel T, Yerci O, Ediz B, Kurt E, Demiray M, Gonullu G, Arslan M, Manavoglu O.

Med Oncol. 2004;21(1):53-8. doi: 10.1385/MO:21:1:53. PMID: 15034214

 

86.   Gastric metastasis of signet ring cell carcinoma of the breast.

Cetintas SK, Kurt M, Ozkan L, Yerci O, Zorluoglu A, Turan-Ozdemir S, Engin K, Gurel S.

Saudi Med J. 2006 Feb;27(2):259-61.

PMID: 16501690 No abstract available.

87.   Lower gastrointestinal tract hemorrhage due to ectopic pancreatic tissue in a renal transplant recipient: a case report.

Ersoy A, Yavuz M, Tokyay R, Yerci O, Kiyici M, Usta M, Güllülü M, Dilek K, Oktay B, Yurtkuran M.

Transplant Proc. 2002 Jun;34(4):1201-3. doi: 10.1016/s0041- 1345(02)02803-8.

PMID: 12072316 No abstract available.

88.   [Evaluation of the ELISA method for the diagnosis of Helicobacter pylori]. Helvaci S, Akdiş C, Gülten M, Yerci O.

Mikrobiyol Bul. 1993 Oct;27(4):294-8. PMID: 8264442 Turkish.

89 [Cytochemical studies for determining the histogenesis of anaplastic and poorly differentiated lung tumors].

Pisiriciler R, Yerci O, Topalidis T, Atay Z. Pneumologie. 1994 Sep;48(9):718-20.

PMID: 7800677 German.

 

90 Pankreas lezyonlarının tanısında ince iğne aspirasyon biyopsisinin yeri Ö Yerci, S GÜREL, H ÖZTÜRK, E DOLAR, ADIM… - Turkish Journal of …, 1999